Clinical Advances in Acute Myeloid Leukemia

CME Activities

• Expert Updates in the Management of AML and CLL CME / CE
  
  

  Experts discuss the latest clinical trial findings for new treatment paradigms in AML and CLL.

  Available As: Download SlidesTranscript
  1.00_CME/CE
• Exploring the Role of Novel Antibodies in AML and Higher-Risk MDS CME / ABIM MOC
  
  

  Dr Sallman brings us up-to-date on advances in antibody-based therapies for AML and higher-risk MDS.

  Available As: Download SlidesTranscript
  0.50_{ABIM MOC}0.50_CME
• Mutational Testing in R/R AML: Who, What, How, and When? CME / ABIM MOC
  
  

  Join the faculty for a discussion on recommendations and guidance for molecular testing in the R/R AML setting.

  Available As: Download SlidesTranscript
  0.50_{ABIM MOC}0.50_CME
• Interactive Case Challenges in Treating Newly Diagnosed AML CME / ABIM MOC
  
  

  Hear the latest developments in the treatment of newly diagnosed AML.

  Available As: Download SlidesTranscript
  0.25_{ABIM MOC}0.25_CME
• Optimizing Available Therapies in AML: Best Practices for Managing Treatment-Related Adverse Events CME / ABIM MOC / CE
  
  

  Gain expert insight on how to best manage the side effects associated with AML therapies.

  1.00_{ABIM MOC}1.00_CME/CE
• Maintenance Treatment in Acute Myeloid Leukemia: Past, Present, and Future  CME / ABIM MOC / CE
  
  

  Join an expert panel for a discussion on the latest advances in maintenance therapy for acute myeloid leukemia (AML).

  Available As: Download SlidesTranscript
  0.50_{ABIM MOC}0.50_CME/CE
• Medical Simulation Challenge: Diagnosing and Treating a Hematologic Malignancy CME / ABIM MOC
  
  Apply best practices to the assessment and personalized management of patients with a hematologic malignancy.
  1.00_{ABIM MOC}1.00_CME
• Maximizing the Use of IDH Inhibitors for the Treatment of AML CE
  
  

  An interprofessional faculty panel provides insights into how to incorporate these targeted therapies into practice.

  1.00_CE
• Treating Acute Myeloid Leukemia: Case Challenges and Emerging Therapies CME / ABIM MOC
  
  The treatment of AML is becoming more complex. Are you aware of the latest approaches?
  Available As: Download SlidesTranscript
  0.50_{ABIM MOC}0.50_CME
• Induction Therapy for the Older/Unfit Patient CME / ABIM MOC
  
  Dr Pollyea discusses the latest advances in lower-intensity induction therapy for patients with AML.
  0.25_{ABIM MOC}0.25_CME
• Personalizing Therapy for FLT3-Mutated Acute Myeloid Leukemia CME / ABIM MOC
  
  Two cases test your knowledge about the treatment of FLT3-mutated AML.
  1.00_{ABIM MOC}1.00_CME
• Expert Recommendations for Treating Newly Diagnosed High-Risk AML CME / ABIM MOC / CEAvailable As: Download SlidesTranscript
  0.50_{ABIM MOC}0.50_CME/CE
• Leveraging Novel Mechanisms for the Treatment of AML CME / ABIM MOC
  
  

  A multidisciplinary panel provides their unique perspectives on the optimal management of patients with high-risk AML.

  1.00_{ABIM MOC}1.00_CME
• IDH Inhibitors in AML CME / ABIM MOC
  
  

  Dr DiNardo reviews molecular testing for IDH mutational status and discusses the use of IDH inhibitors in treatment of AML.

  Available As: Download SlidesTranscript
  0.50_{ABIM MOC}0.50_CME
• The Role of Measurable Residual Disease in AML CME / ABIM MOC
  
  

  Drs Levine and Guzman discuss how to assess MRD in patients with AML and how to use MRD in clinical practice.

  Available As: Slides/VideoDownload SlidesTranscript
  0.50_{ABIM MOC}0.50_CME
• FLT3 Inhibitors in AML CME
  
  

  Dr Harry Erba discusses the latest data on FLT3 inhibitors in AML and how they may affect clinical practice.

  Available As: Download SlidesTranscript
  0.50_CME